Prognostic value of ERBB4 expression in patients with triple negative breast cancer

BACKGROUND: Triple-negative breast cancer (TNBC) is known for aggressive biologic features and poor prognosis. Epidermal growth factor receptor (EGFR) overexpression in TNBC indicates poor prognosis. However, there is no previous study of the relationship between expression of the entire human epide...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Ji-Yeon, Jung, Hae Hyun, Do, In-Gu, Bae, SooYoun, Lee, Se Kyung, Kim, Seok Won, Lee, Jeong Eon, Nam, Seok Jin, Ahn, Jin Seok, Park, Yeon Hee, Im, Young-Hyuck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763414/
https://www.ncbi.nlm.nih.gov/pubmed/26907936
http://dx.doi.org/10.1186/s12885-016-2195-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763414/
https://www.ncbi.nlm.nih.gov/pubmed/26907936
http://dx.doi.org/10.1186/s12885-016-2195-3

Ejemplares similares